AXONICS F-15® Neurostimulator

Implant Manual Recharge-Free | Model 4101

Rx only

Axonics® and Axonics Sacral Neuromodulation System® are trademarks of Axonics, Inc., registered or pending registration in the U.S. and other countries.

LABEL SYMBOLS

This section explains the symbols found on the product and packaging.

Symbol Description
[Image of Axonics Neurostimulator] Axonics Neurostimulator
[Image of Axonics Torque Wrench] Axonics Torque Wrench
[Diagram: 14 Hz, 0 mA, 210 µs pulse width] Neurostimulator default waveform with 14 Hz frequency, 0 mA amplitude and 210 µs pulse width
[Diagram: Electrode configuration] Neurostimulator default electrode configuration: Electrode 0: negative (-)
Electrode 1: Off (0)
Electrode 2: Off (0)
Electrode 3: Positive (+) Case: Off (0)
[SN] Product Serial Number
[REF] Manufacturer
[REF] Product Model Number
[Calendar icon] Manufacturing Date
☢️ [Non-ionizing electromagnetic radiation] Non-ionizing electromagnetic radiation
? [Web link icon] Refer to instructions for use available electronically. (http://www.axonics.com/elFU)
?️ [Temperature icon] Temperature limitation
? [Humidity icon] Humidity limitation
? [Pressure icon] Pressure limitation
?? [Do not reuse icon] Do not reuse
⚕️ [Sterilized icon] Sterilized using Ethylene oxide
? [Use by icon] Use by
?? [Damaged package icon] Do not use if package is damaged
?♻️ [Do not re-sterilize icon] Do not re-sterilize
➡️ [Open here icon] Open here
??⚕️ [USA prescription only icon] For USA audiences only
Caution: U.S. Federal law restricts this device for sale by or on the order of a physician
⚠️ [Warning icon] Warning / Caution
? [Document icon] Product Literature
? [Magnet icon] Magnetic Resonance (MR) Conditional
?? [Canada flag icon] Industry Canada certification number
?? [Australia flag icon] This device complies with all applicable Australian Communications and Media Authority (ACMA) regulatory arrangements and electrical equipment safety requirements
?? [USA flag icon] US Federal Communications Commission device identification
?️ [Shield icon] This device is packaged in two sterile barriers
⚡ [Lead icon] The Neurostimulator is connected to the Axonics Tined Lead Model 1201 (also included in Model 2201)

INTRODUCTION

This manual provides information about the Axonics Sacral Neuromodulation (SNM) System Neurostimulator (Model 4101), which is a part of the Axonics SNM System. The Neurostimulator is connected to the Axonics Tined Lead (Model 1201 or 2201).

INDICATIONS, WARNINGS, AND PRECAUTIONS

These inserts and booklets can be found at www.axonics.com/eIFU.

DEVICE DESCRIPTION

The Axonics Recharge-Free Neurostimulator (Figure 1) is part of the Axonics SNM System. The Neurostimulator is a programmable device that is connected to the Axonics Tined Lead, which conducts stimulation pulses to the sacral nerve.

Figure 1: Axonics Recharge-Free Neurostimulator.

[Image of the Axonics Recharge-Free Neurostimulator. It is a small, rectangular device with rounded edges, featuring the Axonics logo, model number 'REF 4101', and serial number 'SN AX1T000000'.]

Package Contents

The Neurostimulator package contains the following:

The contents of the inner package are STERILE. The contents of the Neurostimulator package are intended for single use only.

System Registration Form and Patient Identification Card

The system registration form registers the device and creates a record of the device in Axonics' implant data system. The patient identification card is also packaged with this device. The patient should carry the identification card at all times.

STORAGE AND USAGE ENVIRONMENT

Component Packaging

Any component that has been compromised in any way should not be implanted; this includes the re-use of non-reusable product. Do not implant the component if any of the following have occurred:

Usage Environment

The following lists the appropriate temperature, humidity, and pressure usage conditions for use of the Neurostimulator:

Shipping and Storage Environment

The following lists the appropriate temperature, humidity, and pressure conditions for shipping and storing the Neurostimulator:

If the Neurostimulator is exposed to extreme temperatures, it may be permanently damaged and should not be used, even if it has returned to a temperature that is within the specified operating range.

Sterilization

The contents of this package have been sterilized using ethylene oxide. This device is for single use only and should not be re-sterilized.

SPECIFICATIONS

Table 1 shows the Neurostimulator physical specifications. For detailed descriptions and specifications for other components and accessories, refer to the product literature for those devices.

Table 1: Neurostimulator Specifications.

Physical Attributes
Height39 mm
Length53 mm
Thickness6.7 mm
Weight24.5 g
Volume10 cc
Radiopaque identifierRDP
Stimulation Characteristics
Frequency2 – 50 Hz
Pulse Width60 – 330 µs
Amplitude0 – 8 mA
Minimum Amplitude Step Size0.05 mA
Ramping0 – 30 s
Stimulation ModeContinuous or Cycling
Mode of OperationCurrent-Controlled

Note: All dimensions are approximate.

Table 2: Neurostimulator Expected Usable Life

Note: This table shows the expected life of the Neurostimulator, estimated at typical stimulation settings: Bipolar Lead Configuration, Frequency 14 Hz, Pulse Width 210 µs, continuous stimulation, impedance = 1200 Ω.

Stimulation Amplitude 0.5 mA 1.3 mA 2.0 mA 3.0 mA
Life (Years) 22 15 9 5

Note: The neurostimulator battery may last longer than 22 years at lower energy use settings.

Table 3: Human-Contact Materials.

Device Component Material
Neurostimulator Neurostimulator case Titanium
Neurostimulator headerEpoxy
Septum and strain reliefSilicone
SetscrewTitanium
AdhesiveSilicone
Torque wrench Torque wrench handle Polyetherimide
Torque wrench shaftStainless steel

Note: The Neurostimulator case, which contains the electronics and power source, is hermetically sealed.

X-RAY IDENTIFICATION

The radiopaque marker allows physicians to identify the manufacturer and model number under standard x-ray procedures. For the Axonics Neurostimulator, the designated code is RDP, which appears as light characters on a black background (Figure 2).

Figure 2: The Axonics Neurostimulator radiopaque marker, “RDP”.

[Diagram showing the Axonics Neurostimulator with a radiopaque marker labeled 'RDP'. The marker appears as light characters on a black background.]

NEUROSTIMULATOR IMPLANT PROCEDURE

The following section describes the procedure for implanting the Axonics Neurostimulator. This procedure should be performed when an Axonics tined lead has already been implanted.

Procedure Supplies

In addition to the general surgical tools required by the physician, the following supplies are needed for the preparation, implantation, programming, and Remote Control pairing of the Neurostimulator:

⚠️ The user should avoid damaging the Neurostimulator and be especially cautious using sharp instruments as damage to the Neurostimulator may require a surgical replacement.

Neurostimulator Preparation

Before opening the sterile Neurostimulator package, the Clinician Programmer (CP) should be used to communicate with the Neurostimulator to verify the ability to communicate and confirm the battery status of the Neurostimulator. Refer to the CP Manual for further instructions.

Creating the Neurostimulator Pocket

  1. The Neurostimulator will be placed in a subcutaneous pocket at the anterior surface of the muscle in the upper buttock area. Create a small incision, approximately 4 cm in length which is slightly longer than the smaller dimension of the Neurostimulator, and then bluntly dissect a subcutaneous pocket.

Notes:

Figure 3: Axonics Neurostimulator Implantation Position.

[Diagram illustrating the Axonics Neurostimulator implantation position in the upper buttock area, showing the subcutaneous pocket and the placement relative to the skin.]

⚠️ The Neurostimulator implant site should be irrigated sterile saline or water, and it is recommended that IV antibiotics be administered perioperatively. Do not soak the Neurostimulator in antibiotic solution as this may affect lead connections.

⚠️ The Neurostimulator has been sterilized. The Neurostimulator should not be placed on any non-sterile surface. The Neurostimulator should not be placed on skin. An infection may require surgical removal of the implanted system.

  1. Use the tunneling tool to create a tunnel from the lead incision site to the neurostimulator pocket. Refer to the Tined Lead Manual for detailed tunneling and lead implant instructions.

Connecting the Lead to the Neurostimulator

  1. The components should be wiped and dried to remove any fluids before making the connections. If necessary, use sterile water or a non-ionic antibiotic solution, then wipe dry.

⚠️ Failure to completely dry the components could lead to undesired stimulation, intermittent stimulation, or loss of therapy.

  1. Ensure that the Neurostimulator connector block is dry and clean.
  2. Use the torque wrench to turn the setscrew counterclockwise to back up the setscrew. (Figure 4).
Figure 4: Use the Torque Wrench to Turn the Setscrew Counterclockwise to Back up the Neurostimulator Setscrew and Allow for Insertion of the Lead.

[Illustration showing a torque wrench being used to turn a setscrew counterclockwise on the Neurostimulator connector block, preparing it for lead insertion.]

  1. Insert the lead into the Neurostimulator connector block until fully seated and the lead cannot be inserted further. Marker D on the lead should be inside the Neurostimulator strain relief (Figure 5). The retention sleeve on the tined lead should be positioned under the Neurostimulator setscrew.
Figure 5: Insert Lead Fully into the Neurostimulator Connector Block.

[Diagram showing a lead being inserted fully into the Neurostimulator connector block. Marker D on the lead is shown inside the strain relief, and the retention sleeve is positioned under the setscrew.]

⚠️ Avoid pulling the lead body taut when implanted.

⚠️ Do not attempt to insert the lead into the Neurostimulator if the setscrew is not sufficiently retracted as doing so may cause damage to the lead and/or cause the lead to not seat fully into the connector block.

⚠️ Ensure that the setscrew tightens on the retention sleeve, not an electrode. Tightening the setscrew onto the contact could damage the contact, leading to lack of therapy.

  1. Fully insert the torque wrench into the hole of the Neurostimulator connector block. Tighten the setscrew by turning the torque wrench clockwise until it clicks (Figure 6).
Figure 6: Secure the Lead by Tightening the Setscrew Clockwise onto the Retention Sleeve.

[Illustration showing a torque wrench fully inserted and tightening the setscrew clockwise onto the lead's retention sleeve.]

⚠️ Ensure that the torque wrench is fully inserted into the setscrew. Otherwise, the setscrew may be damaged, which can result in intermittent or loss of stimulation.

⚠️ The torque wrench is designed for single use only and cannot be assured to work appropriately if used for multiple surgeries. Discard the torque wrench after use.

Implanting the Neurostimulator

  1. Place the Neurostimulator into the subcutaneous pocket. The etched writing can face either towards or away from the skin incision. Ensure that the lead curves gently away from the Neurostimulator with no sharp bends.

Note: The Neurostimulator should be placed no deeper than 3.0 cm (about 1 in) below the skin and should be parallel to the skin. If the Neurostimulator is too deep, telemetry may be unsuccessful.

⚠️ Do not coil excess length in front of Neurostimulator. Wrap excess length around the perimeter of the Neurostimulator (Figure 7) or place under the Neurostimulator to minimize interference with telemetry during programming.

Figure 7: Wrap Excess Lead Around or Under, but not on Top of, the Neurostimulator.

[Diagrams illustrating correct and incorrect placement of excess lead length. The correct method shows excess lead wrapped around or under the Neurostimulator, not on top.]

  1. Use the Clinician Programmer to check the impedances and ensure good function and connectivity of the system.

Notes:

Completing the Implant Procedure

  1. Close and dress all incisions.
  2. Any opened or used products which are no longer sterile should be discarded appropriately. It is recommended to recycle non-biohazardous waste to the extent possible.
  3. Program the patient's Neurostimulator and Remote Control. Refer to the Clinician Programming Manual for more detailed instruction.
  4. Give a Remote Control and patient ID card to the patient.

⚠️ The patient should carry the Remote Control at all times to be able to adjust or turn off the Neurostimulator.

  1. Complete the system registration paperwork and return to Axonics.
  2. Schedule the patient's follow-up visits at regular intervals to ensure that the stimulation is programmed optimally.

Post-Surgery Management

Patients should be monitored post implant. Administer prophylactic antibiotics for 24 hours. Patients should avoid sudden movements and putting pressure on implant site. This will reduce risk of movement or migration of the implanted system.

Replacing the Neurostimulator

Removal of the Neurostimulator is recommended at the end of useful life, which will vary depending on individual stimulation parameters.

  1. Carefully open the implant site and remove the Neurostimulator from the subcutaneous pocket. Avoid cutting the tined lead to preserve for connection with the new Neurostimulator.
  2. Clean the Neurostimulator connector block and lead with sterile water. Wipe both dry with sterile gauze.
  3. Use the torque wrench to loosen the setscrew in the Neurostimulator connector block by turning it counterclockwise (Figure 5).
  4. Gently remove the lead from the Neurostimulator.

⚠️ Replace any device that shows signs of damage, pitting, or corrosion.

  1. Set aside the explanted components.
  2. Connect the lead and replacement Neurostimulator according to the steps above.

Dispose of explanted devices as bio-hazardous waste.

WIRELESS COMMUNICATION

Model: 4101
FCC ID: 2AEEGT
IC: 20225-T

FCC Compliance

This device complies with part 15 of the FCC Rules. Operation is subject to the following two conditions: (1) This device may not cause harmful interference, and (2) This device must accept any interference received, including interference that may cause undesired operation.

This transmitter is authorized by rule under the Medical Device Radio communication Service (in part 95 of the FCC Rules) and must not cause harmful interference to stations operating in the 400.150–406.000 MHz band in the Meteorological Aids (i.e., transmitters and receivers used to communicate weather data), the Meteorological Satellite, or the Earth Exploration Satellite Services and must accept interference that may be caused by such stations, including interference that may cause undesired operation.

This transmitter shall be used only in accordance with the FCC Rules governing the Medical Device Radio Communication Service. Analog and digital voice communications are prohibited. Although this transmitter has been approved by the Federal Communications Commission, there is no guarantee that it will not receive interference or that any particular transmission from this transmitter will be free from interference.

IC Compliance

This device complies with Industry Canada license-exempt RSS standard(s). Operation is subject to the following two conditions: (1) this device may not cause interference, and (2) this device must accept any interference, including interference that may cause undesired operation of this device.

FCC and IC Compliance

This device may not interfere with stations operating in the 400.150–406.000 MHz band in the Meteorological Aids, Meteorological Satellite, and Earth Exploration Satellite Services and must accept any interference received, including interference that may cause undesired operation.

Note: Changes and modifications to the Neurostimulator are not authorized by Axonics could void FCC and IC certification and negate the user's authority to use the product.

Quality of Wireless Service

This device operates in the 402-405 MHz frequency and the maximum effective radiated power of the Neurostimulator communication is below the limit of 25 µW ERP/EIRP as specified in EU: EN ETSI 301-839 and USA: FCC 47 CFR Part 95; Subpart I. The Remote Control or Clinician Programmer must be within 1 meter from the implant for successful communication.

Wireless Security

The Neurostimulator can only communicate with a single Remote Control that is paired to it using the Clinician Programmer. Any Axonics Clinician Programmer can communicate with a Neurostimulator. Additional mechanisms exist to ensure the integrity of radio data.

CUSTOMER SERVICE

For questions regarding the Axonics SNM System, call our Customer Support Center toll-free at +1-877-929-6642 or email at customersupport@axonics.com

Additional information and product manuals can be found at our website: www.axonics.com

Axonics, Inc.

15515 Sand Canyon Ave
Irvine, CA 92618, USA
www.axonics.com
Tel. +1-(877) 929-6642
Fax +1-(949) 396-6321

2025-05
All Rights Reserved. Copyright 2025.
Axonics, Inc.
110-0230-201 Rev D

Models: 4101, 1201, 2201, 4101 Recharge Free, 4101, Recharge Free

File Info : application/pdf, 14 Pages, 4.67MB

110-0230-201rD IPG Implant Manual Model 4101 CA EN

References

Microsoft Word for Microsoft 365

Related Documents

Preview Manuel de l'implant Axonics F-15® Neurostimulateur Sans recharge Modèle 4101
Ce manuel fournit des informations détaillées sur le neurostimulateur Axonics F-15® (modèle 4101), un implant sans recharge pour la neuromodulation sacrée. Il couvre la description du dispositif, les instructions d'implantation, les spécifications techniques, la communication sans fil et le service client.
Preview Axonics R20 Neurostimulator Model 5101 Implant Manual
Implant Manual for the Axonics Rechargeable Neurostimulator, Model 5101. Provides detailed information on device specifications, implantation procedures, usage environment, wireless communication, and customer support.
Preview Axonics F15 Neurostimulator Implant Manual - Model 4101
This implant manual provides detailed information on the Axonics F15 Neurostimulator, Model 4101, including device description, implantation procedures, specifications, and wireless communication.
Preview Axonics Sacral Neuromodulation System Tined Lead Implantation Manual
This manual provides comprehensive information on the implantation procedure for the Axonics Sacral Neuromodulation (SNM) System Tined Lead Sets (models 1201, 2201) and the associated Implant Kit (model 1801). It covers device description, specifications, preparation, step-by-step implantation, testing, tunneling, connections, removal, and customer support.
Preview Axonics Sacral Neuromodulation System: Information for Prescribers and Patients
Explore the Axonics Sacral Neuromodulation System with this guide covering warnings, precautions, intended use, patient counseling, and clinical evaluations for urinary and fecal conditions. Learn about system safety and effectiveness.
Preview Axonics SNM System Patient Information Sheet for Model 4101
Comprehensive patient information sheet for the Axonics Sacral Neuromodulation (SNM) System, Model 4101. Details intended use, device description, safe operation, warnings, risks, precautions, and expected device lifetime for managing urinary and bowel incontinence.
Preview Axonics R15 Neurostimulator Implant Manual (Model 1101)
Implant manual for the Axonics R15 Neurostimulator (Model 1101), detailing specifications, implantation procedure, usage, and wireless communication for the Axonics Sacral Neuromodulation System.
Preview Axonics Sacral Neuromodulation System Tined Lead Implant Manual
This manual provides detailed information on the Axonics Sacral Neuromodulation (SNM) System tined lead (Models 1201, 2201) and the associated lead implantation procedure, including device description, specifications, surgical steps, and post-operative care. It also covers label symbols, storage, and customer service information.